Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) is -3.96% lower on its value in year-to-date trading and has touched a low of $34.69 and a high of $56.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMPH stock was last observed hovering at around $36.24 in the last trading session, with the day’s loss setting it -0.58%.
Currently trading at $35.66, the stock is -5.01% and -15.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing -1.60% at the moment leaves the stock -17.71% off its SMA200. AMPH registered -35.75% loss for a year compared to 6-month gain of -9.54%. The firm has a 50-day simple moving average (SMA 50) of $42.59 and a 200-day simple moving average (SMA200) of $43.37355.
The stock witnessed a -15.58% loss in the last 1 month and extending the period to 3 months gives it a -27.68%, and is -2.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.60% over the week and 4.31% over the month.
Amphastar Pharmaceuticals Inc (AMPH) has around 1761 employees, a market worth around $1.71B and $723.55M in sales. Current P/E ratio is 11.87 and Fwd P/E is 8.71. Profit margin for the company is 21.80%. Distance from 52-week low is 2.80% and -37.31% from its 52-week high. The company has generated returns on investments over the last 12 months (11.66%).
with sales reaching $192.08M over the same period.The EPS is expected to grow by 17.18% this year, but quarterly earnings will post 14.47% year-over-year. Quarterly sales are estimated to grow 7.85% in year-over-year returns.
369.0 institutions hold shares in Amphastar Pharmaceuticals Inc (AMPH), with institutional investors hold 96.86% of the company’s shares. The shares outstanding are 48.37M, and float is at 35.79M with Short Float at 13.45%. Institutions hold 75.15% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.94 million shares valued at $237.7 million. The investor’s holdings represent 12.3258 of the AMPH Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.67 million shares valued at $106.91 million to account for 5.544 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 1.94 million shares representing 4.0339 and valued at over $77.79 million, while TD ASSET MANAGEMENT INC holds 3.5086 of the shares totaling 1.69 million with a market value of $67.66 million.
Amphastar Pharmaceuticals Inc (AMPH) Insider Activity
The most recent transaction is an insider sale by Zhou Rong, the company’s SENIOR EVP, PRODUCTION CENTER. SEC filings show that Zhou Rong sold 8,000 shares of the company’s common stock on Dec 13 ’24 at a price of $45.23 per share for a total of $0.36 million. Following the sale, the insider now owns 0.12 million shares.
Amphastar Pharmaceuticals Inc disclosed in a document filed with the SEC on Dec 12 ’24 that Zhou Rong (SENIOR EVP, PRODUCTION CENTER) sold a total of 7,000 shares of the company’s common stock. The trade occurred on Dec 12 ’24 and was made at $44.42 per share for $0.31 million. Following the transaction, the insider now directly holds 0.12 million shares of the AMPH stock.
Still, SEC filings show that on Dec 09 ’24, PRINS RICHARD K (Director) disposed off 10,000 shares at an average price of $43.77 for $0.44 million. The insider now directly holds 30,471 shares of Amphastar Pharmaceuticals Inc (AMPH).
